Global Pharma Grade Isosorbide Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

According to our (Global Info Research) latest study, the global Pharma Grade Isosorbide market size was valued at US$ 68.51 million in 2025 and is forecast to a readjusted size of US$ 83.01 million by 2032 with a CAGR of 2.8% during review period.
Pharmaceutical-grade isosorbide is a high-purity chemical substance used in the pharmaceutical field. Isosorbide is a diol extracted from plant-derived materials (such as corn starch) and belongs to the cyclic sugar alcohol family. It exhibits good biocompatibility and biodegradability. In the pharmaceutical industry, isosorbide and its derivatives are used to produce drugs for treating cardiovascular diseases, demonstrating good pharmacological activity and safety. Isosorbide is also an effective osmotic oral diuretic. The demand for pharmaceutical-grade isosorbide is estimated at approximately 5,500 tons in 2025.
In recent years, with the continuous development of the global pharmaceutical industry and the ongoing advancement of green chemistry concepts, the market demand for pharmaceutical-grade isosorbide, as an important high-purity bio-based chemical, has steadily increased. Isosorbide is mainly produced by the dehydration of sorbitol, derived from renewable biomass resources such as corn and starch. It possesses good biocompatibility, stability, and low toxicity, and has broad application prospects in pharmaceutical intermediates, pharmaceutical excipients, and functional chemicals. Against the backdrop of the global pharmaceutical industry's increasing demand for high-purity, safe, and sustainable raw materials, the pharmaceutical-grade isosorbide market has gradually attracted attention.
From a demand structure perspective, pharmaceutical intermediates are one of the main application areas for pharmaceutical-grade isosorbide, widely used in the production of cardiovascular drugs such as isosorbide nitrate. Simultaneously, with the development of high-end pharmaceutical formulations and the biopharmaceutical industry, the demand for high-purity bio-based excipients continues to grow, driving the expansion of the pharmaceutical-grade isosorbide market. In some functional formulations and specialty drug systems, isosorbide can also be used as a stabilizer, solvent, or functional additive, providing better safety and stability for the product.
From a technological perspective, the industry is moving towards higher purity, continuous production, and green processes, improving product consistency and yield through optimized catalytic systems and refining processes. Simultaneously, with increasingly stringent global pharmaceutical regulations, product quality control and GMP production capabilities have become crucial competitive factors.
In terms of the industry chain, upstream suppliers include bio-based raw material suppliers such as glucose and sorbitol; midstream is isosorbide producers; and downstream are pharmaceutical intermediate manufacturers and pharmaceutical companies. The industry as a whole has high technological barriers, especially in high-purity refining and quality control, placing high demands on companies' R&D and manufacturing capabilities. As the pharmaceutical industry increasingly focuses on green raw materials and sustainable supply chains, companies with large-scale and high-standard production capabilities hold a leading position in the market.
From a regional market perspective, Europe and North America have stable demand in the high-end pharmaceutical and bio-based chemical sectors, with high requirements for product quality and certification. The Asia-Pacific region has become the fastest-growing region driven by the rapid development of the pharmaceutical manufacturing industry, with significant market potential in China, India, and Japan. Latin America and the Middle East are experiencing gradual demand growth against the backdrop of pharmaceutical industry expansion. Overall, the global market exhibits a parallel development pattern of "high-end + green."
Looking ahead, the global pharmaceutical-grade isosorbide market will be driven by three core factors: first, the continued growth in demand for pharmaceutical intermediates and high-end formulations; second, the strengthening trend of green pharmaceutical manufacturing and bio-based chemicals; and third, the continuous upgrading of high-purity production processes and quality standards. Market growth is not only reflected in the expansion of demand, but also in the increased value brought about by high-value-added pharmaceutical applications.
This report is a detailed and comprehensive analysis for global Pharma Grade Isosorbide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pharma Grade Isosorbide market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Pharma Grade Isosorbide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Pharma Grade Isosorbide market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Pharma Grade Isosorbide market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharma Grade Isosorbide
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharma Grade Isosorbide market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roquette, Yu Teng, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pharma Grade Isosorbide market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
99.5%
99%
Market segment by Application
Cardiovascular Drugs
Dehydration Diuretics
Others
Major players covered
Roquette
Yu Teng
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pharma Grade Isosorbide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pharma Grade Isosorbide, with price, sales quantity, revenue, and global market share of Pharma Grade Isosorbide from 2021 to 2026.
Chapter 3, the Pharma Grade Isosorbide competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharma Grade Isosorbide breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Pharma Grade Isosorbide market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pharma Grade Isosorbide.
Chapter 14 and 15, to describe Pharma Grade Isosorbide sales channel, distributors, customers, research findings and conclusion.